FDA considering yearly Covid vaccine

FDA vaccine advisers are meeting today to discuss the future of Covid vaccination in the U.S.

COLUMBIA, S.C. (WOLO)— FDA vaccine advisers are meeting today to discuss the future of Covid vaccination in the U.S.

Currently, the U.S. offers two types of Covid vaccines, a primary series of shots followed by booster shots. However, a parade of variants has challenged the system.

While nearly 70% of Americans had their primary shots just 15% have gotten a booster.

FDA advisers are considering a shift to a once-a-year Covid shot, similar to the flu vaccine. That shot would likely cover multiple strains of the virus.

Only those with weakened immune systems would then be encouraged to get a second shot.

The advisory committee will also look at how well the current booster shots are working.

A CDC study released Wednesday found that boosters cut the risk of infection by about half and provide even higher protections against severe illness and death.